🎁 Black Friday: up to 50% off of annual plans
Advagene Biopharma Co., Ltd. (TPEX:6709)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.90
-0.20 (-1.00%)
Nov 20, 2026, 1:58 PM CST

Advagene Biopharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1821,6661,2201,3551,4792,396
Market Cap Growth
-28.93%36.50%-9.95%-8.37%-38.27%63.30%
Enterprise Value
8591,5021,1301,2941,3222,125
Last Close Price
19.9027.9120.4525.2829.5948.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.3210.945.539.6811.229.60
P/TBV Ratio
3.3910.945.539.6812.139.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.030.03-0.020.02
Net Debt / Equity Ratio
-0.91-0.86-0.89-0.89-0.77-0.88
Net Debt / EBITDA Ratio
3.581.852.791.400.882.47
Net Debt / FCF Ratio
3.571.992.761.610.923.25
Quick Ratio
44.1913.6331.5618.2514.5129.07
Current Ratio
44.3213.6931.6318.3714.9429.50
Return on Equity (ROE)
-33.48%-36.64%-38.51%-67.80%-62.09%-33.77%
Return on Assets (ROA)
-32.33%-34.25%-36.52%-63.79%-59.00%-32.15%
Return on Capital Employed (ROCE)
-26.00%-45.80%-31.50%-66.70%-90.50%-37.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.62%-4.10%-5.69%-6.80%-8.00%-3.87%
FCF Yield
-7.67%-3.94%-5.83%-5.73%-7.41%-2.83%
Buyback Yield / Dilution
-4.15%-8.64%-8.47%-2.14%-1.23%-9.95%